Iron Triangle Partners’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Iron Triangle Partners’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-190,000	Closed	-$12.1M	–	37
2022 Q4	$12.1M	Sell	190,000 -110,000	-37%	-$7.98M	2.17%	19
2022 Q3	$21.8M	Buy	+300,000	New	+$22.3M	3.81%	10

Other funds holding NARI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Iron Triangle Partners's NARI Position: Q1 2023 in Review

Iron Triangle Partners sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2023, closing a stake of 190,000 shares — an estimated $12.1M sold.

Iron Triangle Partners first reported a position in NARI in Q3 2022 and held it in 2 quarters. The position peaked at $21.8M in Q3 2022. 256 funds tracked by Wall St. Rank hold NARI as of Q1 2023.

Iron Triangle Partners reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Iron Triangle Partners sold 190,000 Inari Medical, Inc. Common Stock shares in Q1 2023, an estimated $12.1M.
Iron Triangle Partners first reported a position in Inari Medical, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
Iron Triangle Partners's Inari Medical, Inc. Common Stock position peaked at $21.8M in Q3 2022.
256 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2023.

Based on Iron Triangle Partners's 13F filing for Q1 2023, filed 15 May 2023.